Amgen Inc. (AMGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
221.53-3.28 (-1.46%)
As of 10:55AM EST. Market open.
| Previous close | 224.81 |
| Open | 224.33 |
| Bid | 221.53 x 1000 |
| Ask | 221.63 x 900 |
| Day's range | 221.03 - 225.28 |
| 52-week range | 177.05 - 264.97 |
| Volume | 542,503 |
| Avg. volume | 2,643,633 |
| Market cap | 128.968B |
| Beta (5Y monthly) | 0.81 |
| PE ratio (TTM) | 17.87 |
| EPS (TTM) | 12.40 |
| Earnings date | 28 Jan 2021 - 01 Feb 2021 |
| Forward dividend & yield | 6.40 (2.85%) |
| Ex-dividend date | 13 Nov 2020 |
| 1y target est | 252.54 |
- Zacks
Amgen (AMGN) Up 1.8% Since Last Earnings Report: Can It Continue?
Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Biotech Stock Roundup: REGN's Cocktail Gets EUA, GILD & AMGN Provide Updates & More
Pipeline and regulatory updates take centerstage in the biotech sector as Regeneron (REGN) and Gilead Sciences (GILD), among others, provide updates on their pipeline candidates.
- Zacks
Amgen (AMGN) Ends Deal With Cytokinetics for Heart Candidate
Amgen (AMGN) will terminate the collaboration with Cytokinetics and transition development and commercialization rights for omecamtiv mecarbil and AMG 594 to the latter.
© 2020 Verizon Media. All rights reserved.
